Some thoughts on the use of replacement alternatives for toxicity testing and risk assessment

By Combes Robert  

Archives of Toxicology, Vol. 83, Iss. 3, 2009-03 ,pp. : 199-201

Springer Publishing Company

Access to resources Recommend Favorite

'A routine thing': clinician strategies for implementing HIV testing for at-risk patients in a busy healthcare organisation (and implications for implementation of other new practice recommendations)

By Sobo Elisa   Bowman Candice   Halloran James   Asch Steven   Goetz Matthew Bidwell   Gifford Allen  

Anthropology & Medicine, Vol. 15, Iss. 3, 2008-12 ,pp. : 213-225

Routledge Ltd

Access to resources Recommend Favorite

Should we implement ‘opt-out’ HIV testing for patients with lymphoma?

By Cave J   Edwards SG   Miller RF   Ardeshna KM   Lee SM  

Clinical Medicine, Vol. 9, Iss. 4, 2009-08 ,pp. : 320-322

Royal College Of Physicians

Access to resources Recommend Favorite

Translational Research in Oncology: The Need of Additional In Vitro Preclinical Testing Methods for New Drugs

By  

Current Pharmaceutical Design, Vol. 18, Iss. 23, 2012-08 ,pp. : 3416-3420

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic testing of embryos: a critical need for data

By Baruch Susannah   Adamson G David   Cohen Jacques   Gibbons William E   Hughes Mark R   Kuliev Anver   Munné Santiago   Rebar Robert W   Simpson Joe Leigh   Verlinsky Yury   Hudson Kathy L  

Reproductive BioMedicine Online, Vol. 11, Iss. 6, 2005-12 ,pp. : 667-670

Reproductive Healthcare Ltd

Access to resources Recommend Favorite